Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2400
mi
from 98109
New York, NY
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2187
mi
from 98109
Ashville, NC
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2187
mi
from 98109
Ashville, NC
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
1565
mi
from 98109
Tulsa, OK
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
147
mi
from 98109
Portland, OR
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2373
mi
from 98109
Philadelphia, PA
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2083
mi
from 98109
Chattanooga, TN
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
701
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2429
mi
from 98109
Norfolk, VA
Click here to add this to my saved trials
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  4/5/2013
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 4/5/2013
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
A Web App for Patients With Alcohol and Drug Use Problems in Primary Care
A Web App for Patients With Alcohol and Drug Use Problems in Primary Care
Status: Enrolling
Updated:  4/11/2013
Behavior Therapy Associates, LLC
1188
mi
from 98109
Albuquerque, NM
A Web App for Patients With Alcohol and Drug Use Problems in Primary Care
A Web App for Patients With Alcohol and Drug Use Problems in Primary Care
Status: Enrolling
Updated: 4/11/2013
Behavior Therapy Associates, LLC
1188
mi
from 98109
Albuquerque, NM
Click here to add this to my saved trials
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
Status: Enrolling
Updated:  4/12/2013
Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
Cognitive Behavioral Treatment of Posttraumatic Stress Disorder Enhanced by Virtual Reality for Individuals With PTSD and Substance Abuse
Status: Enrolling
Updated: 4/12/2013
Weill Medical College of Cornell University
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
Status: Enrolling
Updated:  4/12/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders
Status: Enrolling
Updated: 4/12/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
Status: Enrolling
Updated:  4/16/2013
VA North Texas Health Care System, Dallas
1684
mi
from 98109
Dallas, TX
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
Extinction of Fear Memories With Glucocorticoids in Veterans With PTSD
Status: Enrolling
Updated: 4/16/2013
VA North Texas Health Care System, Dallas
1684
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
Status: Enrolling
Updated:  4/22/2013
Michael Debakey VAMC
1892
mi
from 98109
Houston, TX
Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
Status: Enrolling
Updated: 4/22/2013
Michael Debakey VAMC
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)
Patient Beliefs and Attitudes That Influence Participation in PTSD-TBI Clinical Trials
Status: Enrolling
Updated:  4/24/2013
University of California at San Diego
1063
mi
from 98109
San Diego, CA
Patient Participation Beliefs and Post-Traumatic Stress Disorder (PTSD)
Patient Beliefs and Attitudes That Influence Participation in PTSD-TBI Clinical Trials
Status: Enrolling
Updated: 4/24/2013
University of California at San Diego
1063
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated:  4/26/2013
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
University of Texas M.D. Anderson Cancer Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated:  4/26/2013
Lyndon B. Johnson (LBJ) General Hosptial
1890
mi
from 98109
Houston, TX
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
Assessment of the Prevalence of Sexual Dysfunction, Depression, and Anxiety in Underserved and Minority Patients With Gynecologic Cancers
Status: Enrolling
Updated: 4/26/2013
Lyndon B. Johnson (LBJ) General Hosptial
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated:  4/26/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated: 4/26/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated:  4/26/2013
New York-Presbyterian Hospital
2400
mi
from 98109
New York, NY
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
An Open Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior
Status: Enrolling
Updated: 4/26/2013
New York-Presbyterian Hospital
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Medication and Counseling for Controlled Drinking (Project SMART)
Naltrexone and CBT for Problem-drinking MSM
Status: Enrolling
Updated:  4/30/2013
Research Foundation for Mental Hygiene, Columbia Addiction Services and Psychotherapy Intervention Research, 3 Columbus Circle, Suite 1404
2262
mi
from 98109
New York, NY
Medication and Counseling for Controlled Drinking (Project SMART)
Naltrexone and CBT for Problem-drinking MSM
Status: Enrolling
Updated: 4/30/2013
Research Foundation for Mental Hygiene, Columbia Addiction Services and Psychotherapy Intervention Research, 3 Columbus Circle, Suite 1404
2262
mi
from 98109
New York, NY
Click here to add this to my saved trials
Examining Common Substrates of Eating and Alcohol Use Disorders
Examining Common Substrates of Eating and Alcohol Use Disorders
Status: Enrolling
Updated:  4/30/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Examining Common Substrates of Eating and Alcohol Use Disorders
Examining Common Substrates of Eating and Alcohol Use Disorders
Status: Enrolling
Updated: 4/30/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Examining Common Substrates of Eating and Alcohol Use Disorders
Examining Common Substrates of Eating and Alcohol Use Disorders
Status: Enrolling
Updated:  4/30/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Examining Common Substrates of Eating and Alcohol Use Disorders
Examining Common Substrates of Eating and Alcohol Use Disorders
Status: Enrolling
Updated: 4/30/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
1031
mi
from 98109
Oceanside, CA
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
1031
mi
from 98109
Oceanside, CA
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
705
mi
from 98109
Stanford, CA
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2527
mi
from 98109
Saint Petersburg, FL
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2527
mi
from 98109
Saint Petersburg, FL
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2527
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2485
mi
from 98109
Boston, MA
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
1720
mi
from 98109
St Louis, MO
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
1720
mi
from 98109
St Louis, MO
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2400
mi
from 98109
New York, NY
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2359
mi
from 98109
Norristown, PA
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2359
mi
from 98109
Norristown, PA
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
2486
mi
from 98109
Providence, RI
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
2486
mi
from 98109
Providence, RI
Click here to add this to my saved trials
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated:  4/30/2013
Clinical Research Facility
1864
mi
from 98109
Memphis, TN
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive-Compulsive Disorder
A PHASE II, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE EFFICACY AND SAFETY OF RO4917838 IN COMBINATION WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH OBSESSIVE COMPULSIVE DISORDER
Status: Enrolling
Updated: 4/30/2013
Clinical Research Facility
1864
mi
from 98109
Memphis, TN
Click here to add this to my saved trials
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
A Double-Blind, Placebo-Controlled, Parallel Group Design Trial of; Levetiracetam, Zonisamide, Topiramate, and Placebo Control for the Treatment of Alcohol Dependent Subjects.
Status: Enrolling
Updated:  5/1/2013
Boston University School of Medicine
2485
mi
from 98109
Boston, MA
Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism
A Double-Blind, Placebo-Controlled, Parallel Group Design Trial of; Levetiracetam, Zonisamide, Topiramate, and Placebo Control for the Treatment of Alcohol Dependent Subjects.
Status: Enrolling
Updated: 5/1/2013
Boston University School of Medicine
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa
Physical Activity in Anorexia Nervosa: Characteristics and Clinical Significance
Status: Enrolling
Updated:  5/1/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa
Physical Activity in Anorexia Nervosa: Characteristics and Clinical Significance
Status: Enrolling
Updated: 5/1/2013
New York State Psychiatric Institute
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
Victim Impact Modules for Jail Inmates
Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates
Status: Enrolling
Updated:  5/3/2013
Fairfax County Adult Detention Center
2312
mi
from 98109
Fairfax, VA
Victim Impact Modules for Jail Inmates
Phase 1-2 Study of Victim Impact Group Modules for Jail Inmates
Status: Enrolling
Updated: 5/3/2013
Fairfax County Adult Detention Center
2312
mi
from 98109
Fairfax, VA
Click here to add this to my saved trials
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated:  5/7/2013
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/7/2013
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated:  5/7/2013
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
A Study to Assess the Role of a Gluten Free-Casein Free Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/7/2013
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Sleep Disorders Center of Alabama
2082
mi
from 98109
Birmingham, AL
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Sleep Disorders Center of Alabama
2082
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Pulmonary Associates, PA
1115
mi
from 98109
Phoenix, AZ
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Pulmonary Associates, PA
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Stanford Sleep Medicine Center
701
mi
from 98109
Redwood City, CA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Stanford Sleep Medicine Center
701
mi
from 98109
Redwood City, CA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Pacific Research Network
1063
mi
from 98109
San Diego, CA
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Pacific Research Network
1063
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Sleep-Alertness Disorders Center
mi
from 98109
Aurora, CO
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Sleep-Alertness Disorders Center
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
PAB Clinical Research
2536
mi
from 98109
Brandon, FL
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
PAB Clinical Research
2536
mi
from 98109
Brandon, FL
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated:  5/7/2013
Clinical Research Group of St. Petersburg
2527
mi
from 98109
St. Petersburg, FL
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy
Status: Enrolling
Updated: 5/7/2013
Clinical Research Group of St. Petersburg
2527
mi
from 98109
St. Petersburg, FL
Click here to add this to my saved trials